hs-10342

HR+/HER2- Advanced and/or Metastatic Breast Cancer

Jiangsu Hansoh Pharmaceutical Co., Ltd.Phase 2

—

Rating in progress

hs-10342 in HR+/HER2- Advanced and/or Metastatic Breast Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active